Patients harboring both HLA ≥3 allele mismatches and inhibitory KIR—ligand mismatches had a significantly greater prevalence of viral infection (HR 1.66, p = 0.04) and had poorer outcomes in terms of NRM (HR 1.61, p = 0.05). Here, KIR3DL1 is linked to viral infectious disease.